DaVita receives U.S. subpoena
DaVita Inc., the operator of dialysis centers, received a subpoena from U.S. authorities in Georgia investigating the administration of anemia drugs and vitamin D to kidney patients.
DaVita, based in El Segundo, will produce “a wide range of documents” concerning Abbott Laboratories’ Zemplar, Amgen Inc.’s Epogen, Daiichi Sankyo Co.’s Venofer, Genzyme Inc.’s Hectorol and Watson Pharmaceuticals Inc.’s Ferrlecit, according to a statement.
DaVita said it was working with officials from the U.S. attorney’s office for the northern district of Georgia and the Health and Human Services Department’s Office of Inspector General.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
